The role of hypoxia inducible factor-1alpha in gynecological cancer

Critical Reviews in Oncology/hematology
Laura M S SeeberPaul J van Diest

Abstract

Understanding the mechanisms of carcinogenesis and progression of gynecological tumors is important as these insights might lead to improved diagnostic tools for the pathologist, improved prediction of prognosis, response to therapy, and eventually better biology-based disease management, thereby improving prognosis and quality of life for the individual patient. Hypoxia is an important event in carcinogenesis because it renders a more aggressive phenotype with increased invasiveness and proliferation, formation of metastases and poorer survival. Although selecting patients with hypoxic tumors may therefore be clinically important, there is no consensus as to the method best suited for routine assessment of hypoxia. One of the potential tumor hypoxia markers is hypoxia inducible factor 1 (HIF-1). HIF-1 is the key cellular survival protein under hypoxia, and is associated with tumor progression and metastasis in various solid tumors. In this review, we show that in gynecological cancers, HIF-1A is emerging as an important factor in carcinogenesis, and that overexpression of HIF-1A and its target genes CA9 and SLC2A1 seems associated with shorter progression free- and overall survival. Since hypoxia and HIF-1A expression are asso...Continue Reading

References

Feb 1, 1994·European Journal of Biochemistry·M Mueckler
Jul 1, 1994·Journal of Virology·M S Lechner, L A Laimins
Jan 12, 1996·The Journal of Biological Chemistry·K A Thomas
Feb 1, 1997·Kidney International·R H WengerH H Marti
Nov 5, 1997·Nature Genetics·D KongA Horii
Aug 12, 1998·International Journal of Cancer. Journal International Du Cancer·M HöckelP Vaupel
Dec 28, 1999·Annual Review of Cell and Developmental Biology·G L Semenza
Feb 9, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·T H KnockeR Pötter
Apr 6, 2000·Journal of Applied Physiology·G L Semenza
May 23, 2000·Critical Reviews in Biochemistry and Molecular Biology·G L Semenza
Feb 13, 2001·British Journal of Cancer·P A VaseyS B Kaye
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D RischinR von Roemeling
Jan 24, 2002·Cancer Letters·Kentaro NakayamaYuji Takebayashi
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A FylesR P Hill
Mar 29, 2002·Medical Oncology·P VaupelM Hoeckel
Jul 4, 2002·International Journal of Radiation Oncology, Biology, Physics·Hans Kristian HauglandDavid W Hedley
Nov 21, 2002·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Richard D Vaughan-Jones, Kenneth W Spitzer
May 3, 2003·Cancer Cell·Selma PennacchiettiPaolo M Comoglio
May 10, 2003·International Journal of Radiation Oncology, Biology, Physics·Philipp BurriGünther Gruber
May 22, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Marianne NordsmarkJames A Raleigh
May 23, 2003·Oncogene·Annika UnruhRoland H Wenger
Sep 18, 2003·Nature Reviews. Cancer·Gregg L Semenza
Oct 4, 2003·Nature Reviews. Drug Discovery·Amato GiacciaRandall S Johnson
Dec 17, 2003·Gynecologic Oncology·Cheung WongKaren M Lounsbury
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael B AtkinsMatthew L Sherman
Jun 11, 2004·Cell Cycle·Minori Koshiji, L Eric Huang
Jun 16, 2004·Cancer Metastasis Reviews·Quynh-Thu LeAmato J Giaccia
Sep 24, 2004·International Journal of Radiation Oncology, Biology, Physics·Hitoshi IshikawaTakashi Nakano
Dec 14, 2004·The Oncologist·Peter Vaupel
Dec 14, 2004·The Oncologist·Louis Harrison, Kimberly Blackwell
Dec 17, 2004·Journal of Cellular and Molecular Medicine·Tobias SchmidBernhard Brüne
Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gillian J HutchisonCatharine M L West

❮ Previous
Next ❯

Citations

Aug 13, 2013·Pathology, Research and Practice·Andrzej SemczukWanda M Krajewska
Aug 18, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C ChargariE Deutsch
Apr 10, 2012·The Journal of Clinical Investigation·Federica MaioneEnrico Giraudo
Jul 19, 2012·Biologics : Targets & Therapy·Carole Sourbier
Aug 10, 2012·Experimental & Molecular Medicine·Zhengchao WangYong Cheng
Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Hemant P JoshiSundaram Ramakrishnan
Jul 19, 2013·Breast Cancer Research and Treatment·Aram S A van BrusselPaul M P van Bergen En Henegouwen
May 23, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yue JinYu Wang
Jun 23, 2015·International Journal of Oncology·Quan TianRuifang An
Apr 25, 2012·Critical Reviews in Oncology/hematology·Arne R M van der BiltAnna K L Reyners
May 21, 2013·Cell Biology International·Hong YangBiliang Chen
Oct 27, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Yu-Zhu LiXiao-Dan Zhang
Oct 28, 2016·PloS One·Alina FedoseienkoMarcel A T M van Vugt
Oct 15, 2018·Journal of Cellular Physiology·Vahideh TarhrizShirin Eyvazi
Feb 17, 2018·Behavior Research Methods·Sabine Zinn, Timo Gnambs
Sep 10, 2015·Biomedit︠s︡inskai︠a︡ khimii︠a︡·O E Bryzgunova, P P Laktionov
Aug 17, 2019·Frontiers in Bioengineering and Biotechnology·Felipe EltitRizhi Wang
Aug 16, 2013·Oncology Letters·Yubin MaoHao Yin
Jan 17, 2015·Oncoscience·Georgia A McCannKaruppaiyah Selvendiran
Sep 7, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Qing ChenMei-Mei Guan
Oct 1, 2020·International Journal of Molecular Sciences·Vu Hong Loan NguyenChun Peng
Jun 20, 2017·Molecular Medicine Reports·Pan WangLiang Ming
Feb 12, 2021·Cellular Signalling·MelissaR PitmanStuart M Pitson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
E A GriffithsC M West
Clinica Chimica Acta; International Journal of Clinical Chemistry
Ji-Young LeeDaehee Kang
© 2021 Meta ULC. All rights reserved